Clinical Trial Update: A Study Comparing Mircera and Epoetin Alfa for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Mircera versus epoetin alfa for anemia in dialysis-dependent chronic kidney disease; the study was terminated with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)
• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: TERMINATED | Results posted: 2011-12-14